These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. Qi JH; Claesson-Welsh L Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716 [TBL] [Abstract][Full Text] [Related]
3. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor. Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Kremer C; Breier G; Risau W; Plate KH Cancer Res; 1997 Sep; 57(17):3852-9. PubMed ID: 9288799 [TBL] [Abstract][Full Text] [Related]
5. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Kroll J; Waltenberger J Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473 [TBL] [Abstract][Full Text] [Related]
6. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204 [TBL] [Abstract][Full Text] [Related]